Helenalin, BHM, and BHG suppressed TNBC tumor growth in the xenotransplantation model. (a) The intensity of fluorescence was proportional to tumor size. There was no observable toxicity at 48 hpi after each compound treatment. P denoted as paclitaxel (positive control). (b) The MDA-MB-231 xenotransplantation model was treated in the presence and absence of test compounds, and helenalin, BHM, and BHG significantly inhibited tumor growth after 48 h of treatment. # p < 0.05 compared with the control; * p < 0.05 compared with control cells treated with test compounds. hpi: hours post-treatment or post-injection.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Cancers
Your Input Welcome
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if
additional information is required.
Oops. Something went wrong. Please try again later.